JNJ-64300535
N/A
Report date: 2026/03/23 20:03:44
Base Information
Drug NameJNJ-64300535
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory +[9]
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesIchor Medical Systems IncJohnson & Johnson
China Registration ClassN/A
Develop Information
Active CompaniesJanssen Research & Development Llc
Inactive CompaniesJanssen Sciences Ireland Uc
Active Indications
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A